Phase 2a Clinical Trial of HL237 for Rheumatoid Arthritis

Clinical trial NCT04638426 · UNKNOWN

Trial details

NCT number: NCT04638426
Sponsor: Hanlim Pharm. Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2020-09-10
Primary completion: 2021-05-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.